Skip to main content

Table 1 Subjects’ characteristics

From: Positive association between musclin and insulin resistance in obesity: evidence of a human study and an animal experiment

Variable

Lean

(n = 44)

Overweight/obese

(n = 73)

P value

Age (years)

51.75 ± 13.8

47.89 ± 9.8

0.08

Male/female

21(47.73%)/23

48(65.75%)/25

0.055

T2DM history

28(63.64%)

48(65.75%)

0.816

Current smoker (%)

9(20.45%)

26(35.62%)

0.083

Alcohol use (%)

14(31.82%)

31(42.47%)

0.252

Waist-to-hip ratio

0.9 ± 0.04

0.9 ± 0.05

0.491

Systolic blood pressure (mmHg)

127.36 ± 17.73

132.05 ± 16.73

0.154

Diastolic blood pressure (mmHg)

82.59 ± 9.43

87.68 ± 9.02

0.004**

Total cholesterol (mmol/L)

5.06 ± 1.01

5.36 ± 1.16

0.155

Triglycerides (mmol/L)

1.69 ± 1.41

2.55 ± 2.24

0.025*

High-density lipoprotein (mmol/L)

1.33 ± 0.29

1.26 ± 0.27

0.157

Low-density lipoprotein (mmol/L)

3.07 ± 0.84

3.2 ± 0.81

0.407

Fasting plasma glucose (mmol/L)

7.28 ± 3.29

8.18 ± 3.7

0.186

Fasting serum insulin (mmol/L)

8.46 ± 5.92

13.44 ± 8.70

0.001**

HOMA-IR (μIU x mol/L)

3.02 ± 3.94

5.42 ± 5.19

0.009**

Hemoglobin A1c (%)

6.94 ± 2.32

7.54 ± 2.28

0.173

Musclin(ng/L)

80.39 ± 16.35

89.49 ± 19.00

0.009**

  1. Data are presented as the mean ± standard deviation or as proportions (%)
  2. *P < 0.05 vs. controls, **P < 0.01 vs. controls
  3. T2DM type 2 diabetes mellitus, HOMA-IR homeostasis model assessment of insulin resistance